Compare Mutual Funds
Pros | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 8/8 | 1/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 13 Years 10 Months | 13 Years 10 Months | ||
Fund AUM | ₹9279 Cr | ₹5400 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 1% | 1.02% | ||
Exit Load | 1% | 0.5% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 38 | 36 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 1 | 3 | ||
Top 3 Sectors | Health (100%) |
| ||
Equity % | 97.32% | 98.29% | ||
Debt % | - | 0.05% | ||
P/E | 39.56 | 50.2 | ||
P/B | 5.84 | 6.97 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 0.56% | 1.47% | ||
3-Month Return | 7.79% | 13.25% | ||
6-Month Return | 12.85% | 23.26% | ||
1-Year Return | 13.06% | 23.08% | ||
3-Year Return | 19.19% | 24.71% | ||
5-Year Return | 13.91% | 18.76% |
Sharpe | 0.89 | 1.21 | ||
Alpha | -1.21 | 3.34 | ||
Beta | 0.88 | 0.86 | ||
Standard Deviation | 14.77 | 14.38 | ||
Information Ratio | -0.88 | 0.41 |
Description | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | SBI Healthcare Opportunities Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Sailesh Raj Bhan, Kinjal Desai, Amber Singhania | Tanmaya Desai |

